CNN Anchor Having Double Mastectomy In Wake of Jolie Procedure

Tuesday, 14 May 2013 10:00 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
CNN anchor Zoraida Sambolin said on Tuesday that she had breast cancer and was getting a double mastectomy, following an announcement by actress Angelina Jolie that she had undergone that procedure.
 
Sambolin, who anchors CNN's "Early Start" morning show, discussed her condition on the show while talking about Jolie's preventive double mastectomy.
 
"I struggled for weeks trying to figure out how tell you that I had been diagnosed with breast cancer and was leaving to have surgery," Sambolin, 47, said in a posting to her Facebook page. "Then .. Angelina Jolie shares her story of a double mastectomy and gives me strength and an opening."
 
Sambolin told viewers she was scheduled to have the surgery on May 28.

In a New York Times op-ed piece on Tuesday, Jolie, 37, said she had a preventive double mastectomy after learning she carried a gene that made it very likely she would get breast cancer.

The Oscar-winning actress said she hoped her story would inspire other women fighting the life-threatening disease.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Kids' Get Antibiotics Twice as Often as Needed: Study

Monday, 15 Sep 2014 17:09 PM

Pediatricians prescribe antibiotics about twice as often as they're actually needed for children with ear and throat inf . . .

Bald Men Have Higher Prostate Cancer Risk: Study

Monday, 15 Sep 2014 17:01 PM

Men with male pattern baldness may face a higher risk of developing an aggressive type of prostate cancer than men with  . . .

Drugmaker Agrees to Cheaper Versions of $1,000-a-Pill Hepatitis Med

Monday, 15 Sep 2014 16:51 PM

U.S. drugmaker Gilead Sciences Inc has licensed its hepatitis C drug Sovaldi to seven India-based drugmakers that will s . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved